Skip to main content
. 2022 Apr 5;15:1505–1514. doi: 10.2147/IDR.S356662

Table 2.

The Treatment and Prognosis of Patients Received mNGS and CMT

mNGS Group (n = 33) Non-mNGS Group (n = 66) p value
Antibiotic adjustments (n, %) 23 (70.0%) 29 (43.9%) 0.016
Duration of mechanical Ventilation (hours) 264.0 (154–456) 140.5 (97–261) 0.001
Length of ICU stay (days) 14 (10–23) 9 (6–14) <0.001
Pulmonary infections improved (n, %) 20 (60.6%) 25 (37.9%) 0.032
Mortality in 7 days (n, %) 6.1% (2) 25.8% (17) 0.02
Mortality in 28 days (n, %) 33.3% (11) 31.2% (21) 1
Mortality in 90 days (n, %) 48.5% (16) 45.5% (30) 0.776